SWM
PCRX icon

Spire Wealth Management’s Pacira BioSciences PCRX Stock Holding History

Spire Wealth Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-21
Closed -$543 – 2369
2025
Q4 		$543 Buy
+21
New +$499 ﹤0.01% 2282
2022
Q2 		– Sell
-500
Closed -$38K – 2793
2022
Q1 		$38K Buy
+500
New +$33.3K ﹤0.01% 1552
2021
Q4 		– Sell
-100
Closed -$6K – 2985
2021
Q3 		$6K Sell
100
-500
-83% -$28.8K ﹤0.01% 2245
2021
Q2 		$36K Hold
600
– – ﹤0.01% 1631
2021
Q1 		$42K Buy
+600
New +$42.9K ﹤0.01% 1817

Other funds holding PCRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return